Pregled bibliografske jedinice broj: 1179545
The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities
The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities // Journal of vascular research, 59 (2022), 2; 69-77 doi:10.1159/000521498 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1179545 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Role of ADAMTS-4 in Atherosclerosis and Vessel
Wall Abnormalities
Autori
Novak, Ruđer ; Hrkač, Stela ; Salai, Grgur ; Bilandžić, Joško ; Mitar, Luka ; Grgurević, Lovorka
Izvornik
Journal of vascular research (1018-1172) 59
(2022), 2;
69-77
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
A disintegrin and metalloproteinase with thrombospondin motifs-4 ; Vascular disease ; Atherosclerosis ; Metalloproteinases
Sažetak
Extracellular matrix proteins are regulated by metzincin proteases, like the disintegrin metalloproteinases with thrombospondin motifs (ADAMTS) family members. This review focuses on the emerging role which ADAMTS-4 might play in vascular pathology, which has implications for atherosclerosis and vessel wall abnormalities, as well as for the resulting diseases, such as cardiovascular and cerebrovascular disease, aortic aneurysms, and dissections. Major substrates of ADAMTS-4 are proteoglycans expressed physiologically in smooth muscle cells of blood vessels. Good examples are versican and aggrecan, principal vessel wall proteoglycans that are targeted by ADAMTS-4, driving blood vessel atrophy, which is why this metzincin protease was implicated in the pathophysiology of vascular diseases with an atherosclerotic background. Despite emerging evidence, it is important not to exaggerate the role of ADAMTS-4 as it is likely only a small piece of the complex atherosclerosis puzzle and one that could be functionally redundant due to its high structural similarity to other ADAMTS family members. The therapeutic potential of inhibiting ADAMTS-4 to halt the progression of vascular disease after initialization of treatment is unlikely. However, it is not excluded that it might find a purpose as a biomarker of vascular disease, possibly as an indicator in a larger cytokine panel.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
--KK.01.1.1.01.0008 - Znanstveni centar izvrsnosti za reproduktivnu i regenerativnu medicinu – istraživanja novih platormi i potencijala (CERRM) (Ježek, Davor; Vukičević, Slobodan) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE